Table 4.

Relationship Between Karnofsky Performance Status and Clinical Outcomes of SLKT Recipients (Cohort 2)

	Unadjusted Effect Size	Adjusted Effect Size*
Post-transplant length of stay
Karnofsky A	1 (Ref)	1 (Ref)
Karnofsky B	1.07 (1.00–1.14)	1.04 (0.98–1.12)
Karnofsky C	1.53 (1.43–1.63)	1.18 (1.10–1.27)
Liver graft loss
Karnofsky A	1 (Ref)	1 (Ref)
Karnofsky B	1.09 (0.92–1.30)	1.13 (0.95–1.35)
Karnofsky C	1.31 (1.11–1.54)	1.33 (1.10–1.61)
Kidney graft loss
Karnofsky A	1 (Ref)	1 (Ref)
Karnofsky B	1.08 (0.92–1.27)	1.12 (0.95–1.32)
Karnofsky C	1.33 (1.14–1.55)	1.35 (1.13–1.62)
Patient mortality
Karnofsky A	1 (Ref)	1 (Ref)
Karnofsky B	1.09 (0.92–1.31)	1.26 (0.94–1.35)
Karnofsky C	1.32 (1.12–1.56)	1.32 (1.08–1.61)

Length of stay is presented as ratio of geometric means. Graft loss and patient mortality are presented as hazard ratios.

^*Adjusted for Sex, Race/Ethnicity, Dialysis, MELD, Diabetes, Albumin, Ascites, Encephalopathy, Medical Condition at Transplant, Cirrhosis Etiology, HCC, Region, Transplant Year